Milla Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MILLA PHARMS, and what generic and branded alternatives to MILLA PHARMS drugs are available?
MILLA PHARMS has four approved drugs.
Drugs and US Patents for Milla Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Milla Pharms | SODIUM ACETATE | sodium acetate | INJECTABLE;INJECTION | 214805-001 | May 4, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-001 | Nov 8, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Milla Pharms | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 217308-002 | Jun 7, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-003 | Nov 8, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Milla Pharms | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 212405-001 | Apr 19, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Milla Pharms | SODIUM ACETATE | sodium acetate | INJECTABLE;INJECTION | 214805-002 | Aug 25, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.